Nottingham, UK: A new report, authored by Dr Alyson Connor, a Principal Scientist at Pharmaceutical Profiles Ltd, and published in the latest Drug Delivery Report, outlines a data-driven approach to understanding factors that influence the feasibility of developing a modified release dose form of a new drug. This streamlines the development process, saves a significant amount of time and removes the need for certain animal studies.
